Epstein Secrets

has authorized Chairman Lindsey Graham to issue subpoenas to Facebook CEO Mark Zuckerberg and Twitter CEO Jack Dorsey. The Washington Times (10/22, Lovelace, 492K) says "the forthcoming subpoenas will request the CEO's testimony on the "suppression and/or censorship" of two New York Post articles involvi

ard, not the relatively low bar used this year for emergency use authorization for treatments." Calling the meeting "an usual step," the AE (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust

136185 CNBC <https://www.cnbc.cotn/2020/07/27/dr-anthony-fauci-isnt-particularly-concemed-about-safety-of- moderna-coronavirus-vaccine.html> (7/27, Lovelace, 3.62M) reports on its website that NIAID Director Fauci "said Monday he is 'not particularly concerned' about the safety risk of a potential corona

traub, 10.31M), the Washington Times <https://www.washingtontimes.corn/news/2020/jul/27/virus-vaccine-put-to-final-test-in-thousands-of-vo/> (7/27, Neergaard, 492K), CQ Roll Call <https://www.rollcall.corn/2020/07/27/covid-19-vaccine-trial-update- novembed> (7/27, Siddons, 154K) and New York Times <https:

EO Jack Dorsey. The Washington Times <https://www.washingtontimes.com/news/2020/oct/22/senate-judiciary-committee-votes-subpoena-twitter-/> (10/22, Lovelace, 492K) says "the forthcoming subpoenas will request the CEO's testimony on the "suppression and/or censorship" of two New York Post articles involvi

for treatments." Calling the meeting "an usual step," the AP <https://apnews.corn/article/virus-outbreak- e49203f5c55ba593ca587a56d0116b97> (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust a

Chairman Lindsey Graham to issue subpoenas EFTA00148455 to Facebook CEO Mark Zuckerberg and Twitter CEO Jack Dorsey. The Washington Times (10/22, Lovelace, 492K) says "the forthcoming subpoenas will request the CEO's testimony on the "suppression and/or censorship" of two New York Post articles involvi

ard, not the relatively low bar used this year for emergency use authorization for treatments." Calling the meeting "an usual step," the AP (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust

ay may now be in sight as our current best defense from the virus, social distancing, seems to be crumbling against a wall of denial." CNBC (7/27, Lovelace, 3.62M) reports on its website that NIAID Director Fauci "said Monday he is 'not particularly concerned' about the safety risk of a potential corona

promise, mRNA technology has never been used to make a successful vaccine before." USA Today (7/27, Weintraub, 10.31M), the Washington Times (7/27, Neergaard, 492K), CQ Roll Call (7/27, Siddons, 154K) and New York Times (7/27, Grady, 18.61M), among other news outlets, also report the story. EFTA0015040

ay may now be in sight as our current best defense from the virus, social distancing, seems to be crumbling against a wall of denial." CNBC (7/27, Lovelace, 3.62M) reports on its website that NIAID Director Fauci "said Monday he is 'not particularly concerned' about the safety risk of a potential corona

promise, mRNA technology has never been used to make a successful vaccine before." USA Today (7/27, Weintraub, 10.31M), the Washington Times (7/27, Neergaard, 492K), CQ Roll Call (7/27, Siddons, 154K) and New York Times (7/27, Grady, 18.61M), among other news outlets, also report the story. CNBC (7/27,